Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2026)
Silence Therapeutics recorded quarterly Other Non-Current Assets of $127000.0 in Q1 2026, little changed quarter-over-quarter from $127000.0 in Q4 2025, and down 96.49% year-over-year from $3.6 million in Q1 2025.
Silence Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $127000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 96.49% year-over-year to $127000.0; the TTM figure through Mar 2026 stood at $127000.0 (down 96.49% YoY), while the FY2025 annual figure was $127000.0, down 64.33% from the prior year.
- Other Non-Current Assets came in at $127000.0 for Q1 2026 at Silence Therapeutics, roughly flat from $127000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.9 million in Q2 2025 to a low of $127000.0 in Q4 2025.
- A 4-year average of $2.1 million and a median of $2.9 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 31.3% in 2025 and tumbled 96.49% in 2026, its largest moves.
- Silence Therapeutics' Other Non-Current Assets stood at $3.2 million in 2023, then plunged by 88.88% to $356000.0 in 2024, then sank by 64.33% to $127000.0 in 2025, then changed by 0.0% to $127000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $127000.0, $127000.0, and $399000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 356,000.00 |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.20 Mn |